Evidence map›Paper›PMID 38240591›Full record

ArticleJournal of virology2024

Enterovirus D68 3C protease antagonizes type I interferon signaling by cleaving signal transducer and activator of transcription 1.

Xiaohan Li, Haoran Guo, Jiaxin Yang, Xize Liu, Huili Li, Wanying Yang, Lili Zhang, Yan Li, Wei Wei

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xiaohan LiInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.ORCID 0009-0002-9947-2077
Haoran GuoInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.ORCID 0009-0008-9261-9033
Jiaxin YangInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Xize LiuInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Huili LiInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Wanying YangInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Lili ZhangInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Yan LiInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.
Wei WeiInstitute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin, China.ORCID 0000-0003-4456-840X
Jilin University · CN

Funding

MOST | National Natural Science Foundation of China (NSFC) 32222005, 82372226MOST | National Natural Science Foundation of China (NSFC) 82172246
6 · The paper itself

Abstract

Following the successful control of poliovirus, the re-emergence of respiratory enterovirus D68 (EV-D68), a prominent non-polio enterovirus, has become a serious public health concern worldwide. Host innate immune responses are the primary defense against EV-D68 invasion; however, the mechanism underlying viral evasion of the antiviral activity of interferons (IFN) remains unclear. In this study, we found that EV-D68 inhibited type I IFN signaling by cleaving signal transducer and activator of transcription 1 (STAT1), a crucial factor in cellular responses to interferons and other cytokines. We observed that the prototype and circulating EV-D68 strains conserved their ability to induce STAT1 cleavage and attenuate IFN signal transduction. Further investigation revealed that EV-D68 3C protease cleaves STAT1 at the 131Q residue. Interestingly, not all enterovirus-encoded 3C proteases exhibited this ability. EV-D68 and poliovirus 3C proteases efficiently induced STAT1 cleavage; whereas, 3C proteases from EV-A71, coxsackievirus A16, and echoviruses did not. STAT1 cleavage also abolished the nuclear translocation capacity of STAT1 in response to IFN stimulation to activate downstream signaling elements. Overall, these results suggest that STAT1, targeted by viral protease 3C, is utilized by EV-D68 to subvert the host's innate immune response.IMPORTANCEEnterovirus D68 (EV-D68) has significantly transformed over the past decade, evolving from a rare pathogen to a potential pandemic pathogen. The interferon (IFN) signaling pathway is an important defense mechanism and therapeutic target for the host to resist viral invasion. Previous studies have reported that the EV-D68 virus blocks or weakens immune recognition and IFN production in host cells through diverse strategies; however, the mechanisms of EV-D68 resistance to IFN signaling have not been fully elucidated. Our study revealed that EV-D68 relies on its own encoded protease, 3C, to directly cleave signal transducer and activator of transcription 1 (STAT1), a pivotal transduction component in the IFN signaling pathway, disrupting the IFN-mediated antiviral response. Previous studies on human enteroviruses have not documented direct cleavage of the STAT1 protein to evade cellular immune defenses. However, not all enteroviral 3C proteins can cleave STAT1. These findings highlight the diverse evolutionary strategies different human enteroviruses employ to evade host immunity.

Indexed as

3C Viral ProteasesEnterovirus D, HumanInterferon Type ISignal TransductionAntigens, ViralAntiviral AgentsCysteine EndopeptidasesHost-Pathogen InteractionsHumansImmune EvasionImmunity, InnatePeptide HydrolasesProteolysisSTAT1 Transcription FactorViral Proteins3C Viral ProteasesAntigens, ViralAntiviral AgentsCysteine EndopeptidasesInterferon Type IPeptide HydrolasesSTAT1 Transcription FactorViral Proteins3CEV-D68IFN signalingimmune evasionSTAT1

Identifiers

PMID38240591
PMCPMC10878094
OpenAlexW4391025317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.